Kevin Brown to Phenotype
                            
                            
                                This is a "connection" page, showing publications Kevin Brown has written about Phenotype.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.199
         
        
        
     
 
    
        
        - 
            Defining novel causal SNPs and linked phenotypes at melanoma-associated loci. Hum Mol Genet. 2022 08 25; 31(17):2845-2856.
            
            
                Score: 0.042
             
- 
            Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. Nat Genet. 2020 05; 52(5):494-504.
            
            
                Score: 0.036
             
- 
            Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma. Eur Urol. 2017 11; 72(5):747-754.
            
            
                Score: 0.029
             
- 
            Genome-wide association study identifies multiple risk loci for renal cell carcinoma. Nat Commun. 2017 06 09; 8:15724.
            
            
                Score: 0.029
             
- 
            Whole genome profiling of spontaneous and chemically induced mutations in Toxoplasma gondii. BMC Genomics. 2014 May 10; 15:354.
            
            
                Score: 0.023
             
- 
            Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma. PLoS One. 2012; 7(2):e30398.
            
            
                Score: 0.020
             
- 
            Severe autosomal recessive rippling muscle disease. Muscle Nerve. 2001 Nov; 24(11):1542-7.
            
            
                Score: 0.010
             
- 
            Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet. 2001 Oct; 29(2):143-52.
            
            
                Score: 0.010